Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
PZ Cussons ( (GB:PZC) ) just unveiled an update.
PZ Cussons has appointed Jan Bramall as its new Chief Financial Officer and Board member, effective 23 March 2026, succeeding outgoing CFO Sarah Pollard. Bramall brings extensive international finance and strategy experience from roles at Severfield, Manchester Airports Group, Tyco and Johnson Controls, and will join at what the company describes as a pivotal time following its strategic review, with the board expecting her leadership to support the next phase of growth and improved profitability.
The most recent analyst rating on (GB:PZC) stock is a Hold with a £78.00 price target. To see the full list of analyst forecasts on PZ Cussons stock, see the GB:PZC Stock Forecast page.
Spark’s Take on GB:PZC Stock
According to Spark, TipRanks’ AI Analyst, GB:PZC is a Neutral.
PZ Cussons’ overall stock score reflects a mixed financial performance with challenges in profitability and cash flow. However, positive earnings guidance and strong corporate events suggest potential for improvement. Technical indicators and valuation metrics indicate a cautious market sentiment.
To see Spark’s full report on GB:PZC stock, click here.
More about PZ Cussons
PZ Cussons is a listed consumer goods company headquartered in Manchester, UK, employing around 2,500 people across Europe, Africa, Asia-Pacific and North America. Founded in 1884, it focuses on hygiene, baby and beauty products under well-known brands such as Carex, Childs Farm, Cussons Baby, Imperial Leather, Morning Fresh, Original Source, Premier, Sanctuary Spa and St. Tropez, with sustainability and stakeholder wellbeing central to its strategy.
Average Trading Volume: 753,639
Technical Sentiment Signal: Sell
Current Market Cap: £311.3M
Find detailed analytics on PZC stock on TipRanks’ Stock Analysis page.

